✦ LIBER ✦

Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacy

✍ Scribed by M.E. Burczynski

Book ID: 119380761
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 225 KB
Volume: 186
Category: Article
ISSN: 0378-4274
DOI: 10.1016/j.toxlet.2008.10.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An isolated and perfused organ approach

An isolated and perfused organ approach to validate biomarkers of toxicity identified in metabonomics studies

✍ V. Tagliatti; J.M. Colet; R. Conotte 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Ongoing Clinical Trials Evaluating the C

Ongoing Clinical Trials Evaluating the Cardiovascular Safety and Efficacy of Therapeutic Approaches to Diabetes Mellitus

✍ Vivian A. Fonseca 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 213 KB

Translational approaches and patient pro

Translational approaches and patient profiling to identify relevant biomarkers of interferon beta activity in multiple sclerosis

✍ Ed Croze 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Preclinical Safety Assessment: Current G

Preclinical Safety Assessment: Current Gaps, Challenges, and Approaches in Identifying Translatable Biomarkers of Drug-Induced Liver Injury

✍ Ramaiah, Shashi K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 475 KB

CLINICAL EFFICACY AND SAFETY OF TOLTEROD

CLINICAL EFFICACY AND SAFETY OF TOLTERODINE COMPARED TO PLACEBO IN DETRUSOR OVERACTIVITY

✍ MILLARD, RICHARD; TUTTLE, JOHN; MOORE, KATE; SUSSET, JACQUES; CLARKE, BARTON; DW 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 575 KB

A Systematic Approach to Preclinical and

A Systematic Approach to Preclinical and Clinical Safety Biomarker Qualification Incorporating Bradford Hill's Principles of Causality Association

✍ Chetty, R K; Ozer, J S; Lanevschi, A; Schuppe-Koistinen, I; McHale, D; Pears, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB